294
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Going beyond “same-for-all” testing of infectious agents in donated blood

, , &
Pages 1147-1168 | Received 01 Mar 2013, Accepted 01 Aug 2013, Published online: 28 Jul 2014

References

  • American Cancer Society. (2010) http://www.cancer.org, accessed January 2011.
  • American Red Cross., (2008) Arm to Arm, second edition, American Red Cross.
  • American Red Cross., (2013) Blood testing, available at http://www.redcrossblood.org/learn-about-blood/what-happens-donated-blood/blood-testing, accessed June 2013.
  • AuBuchon, J.P., Birkmeyer, J.D. and Busch, M.P. (1997) Safety of the blood supply in the United States: opportunities and controversies. Annals of Internal Medicine, 127, 904–909.
  • Bajalinov, E.B. (2003) Linear-Fractional Programming: Theory, Methods, Applications and Software, Kluwer Academic Publishers, Norwell, MA.
  • Bazaraa, M.S., Jarvis, J.J. and Sherali, H.D. (2010) Linear Programming and Network Flows, fourth edition, John Wiley & Sons, Inc., Hoboken, NJ.
  • Bazaraa, M.S., Sherali, H.D. and Shetty, C.M. (1993) Nonlinear Programming: Theory and Algorithms, John Wiley & Sons, Inc., New York, NY.
  • Behets, F., Bertozzi, S., Kasali, M., Kashamuka, M., Atikala, L., Brown, C., Ryder, R.W. and Quinn, C. (1990) Successful use of pooled sera to determine HIV-1 deroprevalance in Zaire with development of cost-efficiency models. AIDS, 4, 737–741.
  • Bihl, F., Castelli, D., Marincola, F., Dodd, R.Y. and Brander, C. (2007) Transfusion-transmitted infections. Journal of Translational Medicine, 5(25), 1–11.
  • Bish, D.R., Bish, E.K., Xie, S.R. and Slonim, A.D. (2011) Optimal selection of screening assays for infectious agents in donated blood. IIE Transactions on Healthcare Systems Engineering, 1(2), 67–90.
  • Brandeau, M.L. (2004) Allocating resources to control infectious diseases, Operations Research and Health Care: A Handbook of Methods and Applications, Kluwer, Boston, MA, pp. 443–464.
  • Burns, K.C. and Mauro, C.A. (1987) Group testing with test error as a function of concentration. Communication in Statistics Theory and Methods, 16, 2821–2837.
  • Busch, M.P., Glynn, S.A., Stramer, S.L., Strong, D.M., Caglioti, S., Wright, D.J., Pappalardo, B. and Kleinman, S.H. (2005) A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion, 45(2), 254–264.
  • Busch, M.P., Walderhaug, M., Custer, B., Allain, J.P., Reddy, R. and McDonough, B. (2009) Risk assessment and cost-effectiveness/utility analysis. Biologicals, 37, 78–87.
  • Centers for Disease Control and Prevention. (2011) Progress toward strengthening national blood transfusion services—14 countries, 2008–2010, available at http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6046a2.htm, accessed June 2013.
  • Centers for Disease Control and Prevention. (2013) Blood safety, available at http://www.cdc.gov/bloodsafety/basics.html, accessed June 2013.
  • Charnes, A. and Cooper, W.W. (1962) Programming with linear fractional functionals. Naval Research Logistics, 9, 181–196.
  • Custer, B., Busch, M., Marfin, A.A. and Petersen, L.R. (2005) The cost-effectiveness of screening the U.S. blood supply for the West Nile Virus. Annals of Internal Medicine, 143, 486–492.
  • Dodd, R.Y., Notari, E.P. and Stramer, S.L. (2002) Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion, 42, 975–979.
  • Dow, B.C. (2000) Noise in microbiological screening assays. Transfusion Medicine, 10(2), 97–106.
  • Dzik, W.H. (2005) Technology for enhanced transfusion safety. American Society of Hematology, 1, 476–482.
  • Food and Drug Administration. (2010) Complete list of donor screening assays for infectious agents and HIV diagnostic assays, available at http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/ucm080466.htm, accessed April 2010.
  • Food and Drug Administration. (2013) Ongoing safety efforts, available at http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm048368.htm, accessed June 2013.
  • Greinacher, A., Fendrich, K., Alpen, U. and Hoffmann, W. (2007) Impact of demographic changes on the blood supply: Mecklenburg–West Pomerania as a model region for Europe. Transfusion, 47(3), 395–401.
  • Hillyer, C.D. (2001) Handbook of Transfusion Medicine, Academic Press, San Diego, CA.
  • Hutchinson, A.B., Patel, P., Sansom, S.L., Farnham, P.G., Sullivan, T.J., Bennett, B., Kerndt, P.R., Bolan, R.K., Heffelfinger, J.D., Vimalanand, S.P. and Branson, B.M. (2010) Cost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the United States: a comparison of three public health settings. PLoS Medicine, 7(9), 1–10.
  • Hutton, D.W., Tan, D., So, S.K. and Brandeau, M.L. (2007) Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B. Annals of Internal Medicine, 147, 460–469.
  • Hwang, F.K. (1976) Group testing with a dilution effect. Biometrika, 63, 671–673.
  • Jackson, B.R., Busch, M.P., Stramer, S.L. and AuBuchon, J.P. (2003) The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion, 43, 721–729.
  • Katz, L.M. (2010) Joint statement before the blood products advisory committee—risk of dengue virus infection in blood donors. From the Joint Statement of the AABB, American Red Cross, and America’s Blood Centers, available at http://www.aabb.org/advocacy/statements/Pages/jstatment121410.aspx, accessed: December 2012.
  • Kline, R.L., Brothers, T.A., Brookmeyer, R., Zegger, S. and Quinn, T.C. (1989) Evaluation of human immunodeficiency virus seroprevalance in population surveys using pooled sera. Journal of Clinical Microbiology, 27, 1449–1452.
  • Korves, C.T., Goldie, S.J. and Murray, M.B. (2006) Cost-effectiveness of alternative blood-screening strategies for West Nile virus in the United States. PLoS Medicine, 3(2), 211–221.
  • Lackritz, E., Campbell, C. and Ruebush, T. (1992) Effect of blood transfusion on survival among children in a Kenyan hospital. Lancet, 340, 524–528.
  • Lander, J.J., Gitnick, G.L., Gelb, L.H. and Aach, R.D. (2009) Anticore antibody screening of transfused blood. Vox Sanguinis, 34(2), 77–80.
  • Lara, A.M., Kandulu, J., Chisuwo, L., Kashoti, A., Mundy, C. and Bates, I. (2007) Labaratory costs of a hospital-based blood transfusion service in Malawi. Journal of Clinical Pathology, 58, 56–60.
  • Lefrere, J.J., Coste, J., Defer, C., Loiseau, P., Portelette, E., Mariotti, M., Lerable, J., Rouger, P. and Pawlotsky, J.M. (1998) Screening blood donations for viral genomes: multicenter study of real-time simulation using pooled samples on the model of hepatitis C virus RNA detection. Transfusion, 38(10), 915–923.
  • Leiby, D.A. (2001) Parasites and other emergent infectious agents, in Blood Safety in the New Millenium, American Association of Blood Banks, Bethesda, MD, pp. 55–78.
  • Marshall, D.A., Kleinman, S.H., Wong, J.B., AuBuchon, J.P., Grima, D.T., Kulin, N.A. and Weinstein, M.C. (2004) Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States. Vox Sanguinis, 86, 28–40.
  • Martos, B. (1964) Hyperbolic programming. Naval Research Logistics Quarterly, 11(2), 135–155.
  • Moore, M.C., Howell, D.R. and Barbara, J.A.J. (2007) Donors whose blood reacts falsely positive in transfusion microbiology screening assays need not be lost to transfusion. Transfusion Medicine, 17(1), 55–59.
  • Owusu-Ofori, S., Asenso-Mensah, K., Boateng, P., Sarkodie, F. and Allain, J.P. (2010) Fostering repeat donations in Ghana. Biologicals, 38, 47–52.
  • Pepe, M.S. (2004) The Statistical Evaluation of Medical Tests for Classification and Prediction, Oxford University Press, Oxford, UK.
  • Pierskalla, W. (2004) Supply chain management of blood banks, in Operations Research and Health Care: A Handbook of Methods and Applications, Kluwer, Boston, MA, pp. 103–146.
  • Schwartz, J.S., Kinosian, B.P., Pierskalla, W.P. and Lee, H. (1990) Strategies for screening blood for human immunodeficiency virus antibody. Use of a decision support system. Journal of the American Medical Association, 264(13), 1704–1710.
  • Sendi, P., Al, M.J., Gafni, A. and Birch, S. (2003) Optimizing a portfolio of healthcare programs in the presence of uncertainty and constrained resources. Social Science & Medicine, 57(9), 2207–2215.
  • Stone, P.W., Teutsch, S. and Chapman, R.H. (2000) Cost-utility analyses of clinical preventive services: published ratios, 1976–1997. American Journal of Preventive Medicine, 19, 15–23.
  • Stramer, S.L. (2007) Current risks of transfusion-transmitted agents: a review. Archives of Pathology & Laboratory Medicine, 131, 702–707.
  • Stramer, S.L., Fang, C.T., Foster, G.A., Wagner, A.G., Brodsky, J.P. and Dodd, R.Y. (2005) West Nile virus among blood donors in the United States, 2003 and 2004. New England Journal of Medicine, 353(5), 451–459.
  • Stramer, S.L., Glynn, S.A. and Kleinman, S.H. (2004) Detection of HIV and HCV infections among antibody-negative U.S. blood donors by nucleic acid-amplification testing. New England Journal of Medicine, 351, 760–768.
  • Ubel, P.A., DeKay, M.L., Baron, J. and Asch, D.A. (1996) Cost-effectiveness analysis in a setting of budget constraints: is it equitable?New England Journal of Medicine, 334, 1174–1177.
  • Van Hulst, M., Hubben, G.A.A., Kwamena, W.C.S., Promwong, C., Permpikul, P., Fongsatikul, L., Glynn, D.M., Sibinga, C.T.S. and Postma, M.J. (2009) Web interface supported transmission risk assessment and cost-effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and The Netherlands. Transfusion, 49, 2729–2742.
  • Van Hulst, M., Sibinga, C.T.S. and Postma, M.J. (2010) Health economics of blood transfusion safety—focus on Sub-Saharan Africa. Biologicals, 38, 53–58.
  • Wang, B., Schreiber, G.B., Glynn, S.A., Nass, C.C., Smith, J.W., Higgins, M.J., Hutching, S.T., Wright, D.J., McEntire, R.L. and Murphy, E.L. (2003) Prevalance of transfusion-transmissible viral infections in first-time U.S. blood donors by donation site. Transfusion, 43, 705–712.
  • Weusten, J., van Drimmelen, H. and Lelie, P.N. (2002) Mathematical modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT. Transfusion, 42, 537–548.
  • World Health Organization., (2004) Developing countries face safe blood shortage. Bulletin of World Health Organization, 82(7), 558–558.
  • World Health Organization., (2010) WHO global database on blood safety and blood safety indicators, available at http://www.who.int/bloodsafety/global_database/en/, accessed April 2010.
  • World Health Organization., (2011) Screening donated blood for transfusion transmissible infections—recommendations, available at http://www.who.int/bloodsafety/ScreeningDonatedBloodforTransfusion.pdf, accessed January 2011.
  • Xie, S.R., Bish, D.R., Bish, E.K., Slonim, A.D. and Stramer, S.L. (2012) Safety and waste considerations in donated blood screening. European Journal of Operational Research, 217(3), 619–632.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.